Cyclosporine enhances vasorelaxation in coronary but not pulmonary artery after 16-hour preservation with UW solution.
作者： Y Chu , Y.C Wu , Y.C Chou , H.P Liu , J.J Chu
DOI: 10.1016/J.TRANSPROCEED.2003.10.071
关键词:
摘要: Cyclosporine (CsA), a calcineurin inhibitor, has been associated with endothelial dysfunction in transplant patients. Human and vitro studies suggest that CsA produces by impairing vascular endothelium-dependent relaxation. However, little is know about the effects to modulate vasorelaxation after prolonged graft preservation. In this study using protocol designed eliminate influences of infusion pressure shear stress, we evaluated effect on coronary pulmonary arteries 16-hour University Wisconsin (UW) solution
elsevier.com
sci-hub.se 参考文章(12)
Cyril A. Ovuworie, Ervin R. Fox, Chi-Ming Chow, Manuel Pascual, Vivian E. Shih, Michael H. Picard, Nina E. Tolkoff-Rubin, Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation. ,vol. 72, pp. 1385- 1388 ,(2001) , 10.1097/00007890-200110270-00009
Nicholas T. Richards, Lucilla Poston, Philip J. Hilton, Cyclosporine A inhibits relaxation but does not induce vasoconstriction in human subcutaneous resistance vessels. Journal of Hypertension. ,vol. 7, pp. 1- 3 ,(1989) , 10.1097/00004872-198901000-00001
M.H.C Richter, H Richter, M Barten, D Schramm, M Weinert, J Gummert, F.W Mohr, H.G Olbrich, Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model. International Congress on Immunosuppression. ,vol. 34, pp. 1479- 1480 ,(2002) , 10.1016/S0041-1345(02)02938-X
Thomas N. Masters, Alexander A. Fokin, Jutta Schaper, Silja Lorenz-Meyer, Lieven Pool, Geoffrey Gong, Francis Robicsek, Extending myocardial viability during heart preservation with cyclosporine A. Journal of Cardiac Surgery. ,vol. 15, pp. 392- 402 ,(2010) , 10.1111/J.1540-8191.2000.TB01299.X
M. Weis, S.M. Wildhirt, C. Schulze, S. Pehlivanli, B.M. Meiser, P. Überfuhr, W. von Scheidt, Impact of immunosuppression on coronary endothelial function after cardiac transplantation. Congress of The Turkish Transplantation Society. ,vol. 30, pp. 871- 872 ,(1998) , 10.1016/S0041-1345(98)00081-5
Gregory J Dusting, Kazuhiro Akita, Haruyo Hickey, Melanie Smith, Vladimir Gurevich, Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms British Journal of Pharmacology. ,vol. 128, pp. 337- 344 ,(1999) , 10.1038/SJ.BJP.0702782
K Sudhir, J S MacGregor, T DeMarco, C J De Groot, R N Taylor, T M Chou, P G Yock, K Chatterjee, Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation. ,vol. 90, pp. 3018- 3023 ,(1994) , 10.1161/01.CIR.90.6.3018
Scott T.W. Morris, John J.V. Mcmurray, R. Stuart C. Rodger, Rosemary Farmer, Alan G. Jardine, Endothelial dysfunction in renal transplant recipients maintained on cyclosporine Kidney International. ,vol. 57, pp. 1100- 1106 ,(2000) , 10.1046/J.1523-1755.2000.00937.X
Nicholas T. Richards, Lucilla Poston, Philip J. Hilton, Cyclosporin A inhibits endothelium-dependent, prostanoid-induced relaxation in human subcutaneous resistance vessels. Journal of Hypertension. ,vol. 8, pp. 159- 163 ,(1990) , 10.1097/00004872-199002000-00010
Erik S.G. Stroes, Thomas F. Lüscher, Flip G. de Groot, Hein A. Koomans, Ton J. Rabelink, Cyclosporin A Increases Nitric Oxide Activity In Vivo Hypertension. ,vol. 29, pp. 570- 575 ,(1997) , 10.1161/01.HYP.29.2.570